Metraipolis › archive › dc_beb67abfc4de

Immune-mediated gastritis in a patient with breast cancer due to therapy with immune checkpoint inhibitor pembrolizumab: a case report — Europe PMC PMID:41142620

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41142620
DOI
10.3389/fonc.2025.1624185
License (as archived)
solo-consultazione
Archived
2026-11-09T10:16:29.377Z
SHA-256 of the archived text
668b28a41dea49f7b877880ce20f1de91a5a874f9c1c57f21830322f238ba4af
Stable URL of this page
https://metraipolis.com/documento/dc_beb67abfc4de

How to cite

Immune-mediated gastritis in a patient with breast cancer due to therapy with immune checkpoint inhibitor pembrolizumab: a case report — Europe PMC PMID:41142620 — Europe PMC (en), https://europepmc.org/article/MED/41142620 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_beb67abfc4de (Metraipolis archive dc_beb67abfc4de, sha256 668b28a41dea49f7b877880ce20f1de91a5a874f9c1c57f21830322f238ba4af)
BibTeX
@misc{dcbeb67abfc4de,
  title = {Immune-mediated gastritis in a patient with breast cancer due to therapy with immune checkpoint inhibitor pembrolizumab: a case report — Europe PMC PMID:41142620},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41142620},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_beb67abfc4de; sha256 668b28a41dea49f7b877880ce20f1de91a5a874f9c1c57f21830322f238ba4af},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41142620. Agents can read the archived copy with the MCP tool read_document.